Sign Up to like & get
recommendations!
0
Published in 2017 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520617666170522120200
Abstract: BACKGROUND Bendamustine, an N-mustard-benzoimidazole hybrid conjugate, was recently approved for the treatment of chronic lymphocytic leukemia. However, the short half-life of bendamustine may limit its clinical applications. OBJECTIVE The purpose of this study is to…
read more here.
Keywords:
phenyl mustard;
mustard benzimidazoles;
mustard;
novel mustard ... See more keywords